These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

873 related items for PubMed ID: 24572675

  • 21. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
    Kaliki S, Shields CL, Shah SU, Eagle RC, Shields JA, Leahey A.
    Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
    [Abstract] [Full Text] [Related]

  • 22. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL, Shelil A, Cater J, Meadows AT, Shields JA.
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [Abstract] [Full Text] [Related]

  • 23. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
    Smith SJ, Pulido JS, Salomão DR, Smith BD, Mohney B.
    Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261
    [Abstract] [Full Text] [Related]

  • 24. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL, Douglass AM, Beggache M, Say EA, Shields JA.
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [Abstract] [Full Text] [Related]

  • 25. Sudden dispersion of retinoblastoma shortly after initial chemotherapy treatment.
    Parness-Yossifon R, Bryar PJ, Weinstein JL, Srikumaran D, Mets MB.
    Am J Ophthalmol; 2009 May; 147(5):903-6. PubMed ID: 19232557
    [Abstract] [Full Text] [Related]

  • 26. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C, Wilson MW, Haik BG, Merchant TE, Billups CA, Shah N, Cain A, Langston J, Lipson M, Kun LE, Pratt CB.
    J Clin Oncol; 2003 May 15; 21(10):2019-25. PubMed ID: 12743157
    [Abstract] [Full Text] [Related]

  • 27. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
    Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, Rosenwasser R, Shields JA.
    Arch Ophthalmol; 2011 Nov 15; 129(11):1399-406. PubMed ID: 21670328
    [Abstract] [Full Text] [Related]

  • 28. Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
    Rojanaporn D, Kaliki S, Bianciotto CG, Iturralde JC, Say EA, Shields CL.
    Arch Ophthalmol; 2012 May 15; 130(5):585-90. PubMed ID: 22652844
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ.
    Am J Ophthalmol; 2002 May 15; 133(5):657-64. PubMed ID: 11992863
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
    Künkele A, Jurklies C, Wieland R, Lohmann D, Bornfeld N, Eggert A, Schulte JH.
    Br J Ophthalmol; 2013 Oct 15; 97(10):1277-83. PubMed ID: 23863458
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
    Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, Beck-Popovic M.
    Br J Ophthalmol; 2012 Aug 15; 96(8):1078-83. PubMed ID: 22694968
    [Abstract] [Full Text] [Related]

  • 39. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP.
    Ophthalmology; 2010 Aug 15; 117(8):1623-9. PubMed ID: 20381868
    [Abstract] [Full Text] [Related]

  • 40. Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?
    Gombos DS, Cauchi PA, Hungerford JL, Addison P, Coen PG, Kingston JE.
    Br J Ophthalmol; 2006 Sep 15; 90(9):1168-72. PubMed ID: 16707528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.